150 related articles for article (PubMed ID: 36443451)
1. Development, validation, and implementation of a robust and quality control-friendly focused peptide mapping method for monitoring oxidation of co-formulated monoclonal antibodies.
Xu C; Khanal S; Pierson NA; Quiroz J; Kochert B; Yang X; Wylie D; Strulson CA
Anal Bioanal Chem; 2022 Dec; 414(29-30):8317-8330. PubMed ID: 36443451
[TBL] [Abstract][Full Text] [Related]
2. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
[TBL] [Abstract][Full Text] [Related]
3. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
4. ID-MAM: A Validated Identity and Multi-Attribute Monitoring Method for Commercial Release and Stability Testing of a Bispecific Antibody.
Evans AR; Hebert AS; Mulholland J; Lewis MJ; Hu P
Anal Chem; 2021 Jul; 93(26):9166-9173. PubMed ID: 34161073
[TBL] [Abstract][Full Text] [Related]
5. A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.
Xu W; Jimenez RB; Mowery R; Luo H; Cao M; Agarwal N; Ramos I; Wang X; Wang J
MAbs; 2017 Oct; 9(7):1186-1196. PubMed ID: 28805536
[TBL] [Abstract][Full Text] [Related]
6. Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy.
Cao M; De Mel N; Shannon A; Prophet M; Wang C; Xu W; Niu B; Kim J; Albarghouthi M; Liu D; Meinke E; Lin S; Wang X; Wang J
MAbs; 2019 Apr; 11(3):489-499. PubMed ID: 30786796
[TBL] [Abstract][Full Text] [Related]
7. Development of a rapid RP-UHPLC-MS method for analysis of modifications in therapeutic monoclonal antibodies.
Zhang B; Jeong J; Burgess B; Jazayri M; Tang Y; Taylor Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():172-181. PubMed ID: 27233581
[TBL] [Abstract][Full Text] [Related]
8. High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation.
Li X; Xu W; Wang Y; Zhao J; Liu YH; Richardson D; Li H; Shameem M; Yang X
J Chromatogr A; 2016 Aug; 1460():51-60. PubMed ID: 27432793
[TBL] [Abstract][Full Text] [Related]
9. Inter-laboratory study of an optimised peptide mapping workflow using automated trypsin digestion for monitoring monoclonal antibody product quality attributes.
Millán-Martín S; Jakes C; Carillo S; Buchanan T; Guender M; Kristensen DB; Sloth TM; Ørgaard M; Cook K; Bones J
Anal Bioanal Chem; 2020 Oct; 412(25):6833-6848. PubMed ID: 32710279
[TBL] [Abstract][Full Text] [Related]
10. Fast analysis of antibody-derived therapeutics by automated multidimensional liquid chromatography - Mass spectrometry.
Pot S; Gstöttner C; Heinrich K; Hoelterhoff S; Grunert I; Leiss M; Bathke A; Domínguez-Vega E
Anal Chim Acta; 2021 Nov; 1184():339015. PubMed ID: 34625261
[TBL] [Abstract][Full Text] [Related]
11. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
Zhang Z; Yan Y; Wang S; Li N
MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
[TBL] [Abstract][Full Text] [Related]
12. Method validation and new peak detection for the liquid chromatography-mass spectrometry multi-attribute method.
Oyugi M; Wang X; Yang X; Wu D; Rogstad S
J Pharm Biomed Anal; 2023 Sep; 234():115564. PubMed ID: 37451094
[TBL] [Abstract][Full Text] [Related]
13. Determination of protein oxidation by mass spectrometry and method transfer to quality control.
Houde D; Kauppinen P; Mhatre R; Lyubarskaya Y
J Chromatogr A; 2006 Aug; 1123(2):189-98. PubMed ID: 16716331
[TBL] [Abstract][Full Text] [Related]
14. Interlaboratory Co-validation of a UPLC-ToF MS MAM Method for Truncations of a Fc Fusion Protein.
Wu G; Yu C; Tong Q; Wang W; Huang X; Li H; Wang L
Curr Pharm Biotechnol; 2023; 24(10):1315-1325. PubMed ID: 36372921
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
[TBL] [Abstract][Full Text] [Related]
16. Subunit mass analysis for monitoring antibody oxidation.
Sokolowska I; Mo J; Dong J; Lewis MJ; Hu P
MAbs; 2017 Apr; 9(3):498-505. PubMed ID: 28106519
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory Evaluation of a User-Friendly Benchtop Mass Spectrometer for Multiple-Attribute Monitoring Studies of a Monoclonal Antibody.
Butré CI; D'Atri V; Diemer H; Colas O; Wagner E; Beck A; Cianferani S; Guillarme D; Delobel A
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985827
[TBL] [Abstract][Full Text] [Related]
18. A hydrophobic interaction chromatography method suitable for quantitating individual monoclonal antibodies contained in co-formulated drug products.
Luo L; Jiang B; Cao Y; Xu L; Shameem M; Liu D
J Pharm Biomed Anal; 2021 Jan; 193():113703. PubMed ID: 33147536
[TBL] [Abstract][Full Text] [Related]
19. Targeted Bottom-up Characterization of Recombinant Monoclonal Antibodies by Multidimensional LC/MS.
Camperi J; Guillarme D; Stella C
Anal Chem; 2020 Oct; 92(19):13420-13426. PubMed ID: 32901474
[TBL] [Abstract][Full Text] [Related]
20. Isobaric Tandem Mass Tag Multiplexed Post-Translational Modification Quantitation of Biopharmaceuticals by Targeted High-Resolution Mass Spectrometry.
Mao Y; Kleinberg A; Li N
Anal Chem; 2020 Jul; 92(14):9682-9690. PubMed ID: 32559367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
